A Weight-Neutral Approach for a Healthier Lifestyle Among Obesity - A Lifestyle Intervention Anchored in SDOI

Sponsor
Hospital of South West Jutland (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05708417
Collaborator
(none)
120
2
36

Study Details

Study Description

Brief Summary

The study aim is to evaluate a patient-centred intervention focusing on improved quality of life and wellbeing among individuals with obesity and risk factors for adverse outcome.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Lifestyle Intervention
  • Other: Placebo
N/A

Detailed Description

In Denmark, University Hospital of Southern Denmark in Esbjerg has initiated The South Danish Obesity Initiative (SDOI) to optimize the treatment of and the research in obesity. The hospital has for years, offered treatment to individuals with obesity, however, SDOI is an investigation program with the aim to identify people with undiagnosed obesity-related diseases by a systematic and stepwise approach, delivering an up-to-date treatment of diagnosed diseases and offering personalized lifestyle advice based on the finding in the investigation program. The SDOI program comprises collaboration between different medical departments at the hospital and furthermore, entails the establishment of a well-defined cohort as a basis for research. ACT is of interest in the construction of the personalized lifestyle advice in the SDOI program. However, there is limited research available on the effect of the behaviour therapy ACT as a basic method for a lifestyle program targeting overweight individuals who have been made aware of obesity related diseases and re-conditions. ACT might be a valuable tool to assist these individuals to increase their quality of life and thereby, ability to make lifestyle changes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The study is a one-site, single-blind, clinical intervention study.The study is a one-site, single-blind, clinical intervention study.
Masking:
Single (Investigator)
Primary Purpose:
Prevention
Official Title:
A Weight-Neutral Approach for a Healthier Lifestyle Among Obesity - A Lifestyle Intervention Anchored in The South Danish Obesity Initiative (SDOI).
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2026
Anticipated Study Completion Date :
Feb 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Weight neutral intervention

The intervention is based on the concept of Acceptance and Commitment Therapy (ACT) and is conducted by specially trained physiotherapist and a dietician. The intervention in SDOI has the predominantly focus on each individual reflection and realization and is built upon ACT' six core processes. Specific focus on teach participant with different narrative and background and on coaching and back-and-forth dialogue with physiotherapist and dietician. The program is based on up to 13 times attendance within the 12 months intervention period. Part 1: Three to five individual coaching, Part 2: six group sessions and Part 3: one or two individual coaching. Compliance to the intervention is classified as 'good' if the participants participate for a minimum four out of six group sessions, a minimum three out of five initial individual coaching and a minimum one out of two individual coaching post intervention.

Behavioral: Lifestyle Intervention
The intervention in SDOI has the predominantly focus on each individual reflection and realisation and is built upon ACT' six core processes: 1) Acceptance, 2) Cognitive defusion 3) Being present, 4) Self as context, 5) Values, and 6) Committed action. The program is based on up to 13 times attendance within the 12 months intervention period.

Placebo Comparator: Reference group

The reference group will not receive the intervention in the study and only participate in the test/data collection. The reference group will established consisting of participants participating in the SDOI program but, who of some reasons have refused participating in the lifestyle program. In case of insufficient recruitment of participants to the reference group, individuals meeting inclusion criteria such as age and BMI will be recruited via advertising in local newspapers and social media.

Other: Placebo
No lifestyle intervention within the study, only test/datacollection

Outcome Measures

Primary Outcome Measures

  1. HRQoL . [52 weeks]

    Measured by the questionnaire Impact of Weight on Quality of Life-Lite at week 52. Scores range from 0 to 100, with 100 representing the best quality of life.

Secondary Outcome Measures

  1. General physical activity [52 weeks]

    Measured by Accelerometer

  2. Body perception [52 weeks]

    Questionnaire

  3. Isometric muscle strength [52 weeks]

    Measured by Biodex dynanometer

  4. Self-esteem [52 weeks]

    Measured by questionnaire

  5. Total cholesterol (mml/L) [52 weeks]

    Blood sample

  6. Insulin resistance (HOMA-IR) [52 weeks]

    Blood sample

  7. Diastolic and systolic Blood pressure (mm Hg) [52 weeks]

    Blood pressure monitor

  8. Perceived chronic pain [52 weeks]

    Measured on VAS scale. The score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100

  9. Aerobic capacity [52 weeks]

    One-point Åstrand test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants will be eligible for inclusion if they are ≥18 years

  • Body mass index above 30 kg/m2

Exclusion Criteria:
  • Individuals referred for bariatric surgery will not be eligible for inclusion in the study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hospital of South West Jutland

Investigators

  • Study Director: Claus Bogh Juhl, Professor, Hospital of South West Jutland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital of South West Jutland
ClinicalTrials.gov Identifier:
NCT05708417
Other Study ID Numbers:
  • Lifestyle_intervention_SDOI
First Posted:
Feb 1, 2023
Last Update Posted:
Feb 1, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2023